WHILE local generic drug producers battle with various patenting issues, they are not helped by most Malaysians’ perception that generic drugs are inferior because they are cheaper.
Contrary to the misconception, the Malaysian regulatory standard is high and on par with international standards, says Universiti Sains Malaysia School of Pharmaceutical Sciences professor Dr Yuen Kah Hay.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
